To include your compound in the COVID-19 Resource Center, submit it here.

MoxDuo IR morphine/oxycodone regulatory update

QRxPharma began submission of an NDA to FDA for MoxDuo IR morphine/oxycodone to treat

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE